Agilent/Dako

p63 Protein

#IR662 · western blot

9
Citing papers
290
Combined citations
Supplier page Find this product

Research areas

Head and Neck Cancer Studies2Cancer Immunotherapy and Biomarkers1Genetic factors in colorectal cancer1Colorectal and Anal Carcinomas1Congenital Diaphragmatic Hernia Studies1Gastric Cancer Management and Outcomes1Cancer-related Molecular Pathways1Cancer Cells and Metastasis1

Papers citing this product

1
Role of PD-L1 Expression in Non-Small Cell Lung Cancer and Their Prognostic Significance according to Clinicopathological Factors and Diagnostic Markers
International Journal of Molecular Sciences·2019·200 cit.·DOI
2
p40 Immunohistochemistry Is an Excellent Marker in Primary Lung Squamous Cell Carcinoma
Journal of Pathology and Translational Medicine·2018·56 cit.·DOI
3
A tissue-engineered urinary conduit in a porcine urinary diversion model
Scientific Reports·2021·24 cit.·DOI
4
A new heterotropic vascularized model of total urinary bladder transplantation in a rat model
Scientific Reports·2021·4 cit.·DOI
5
Immunohistochemical Expression of Alpha-Methyl-Coa (AMACR) and ERG in Prostatic Adenocarcinoma and Prostatic Hyperplasia: A Comparative Study
Asian Pacific Journal of Cancer Prevention·2023·3 cit.·DOI
6
An unusual non‑metastatic, mismatch repair‑deficient primary gastric squamous cell carcinoma presenting as a large, exophytic, bleeding tumor: A case report
Oncology Letters·2023·3 cit.·DOI
7
PATIENT-DERIVED ORGANOIDS CAPTURE HISTOLOGICAL, MOLECULAR AND THERAPEUTIC HETEROGENEITY IN PHARYNGEAL AND LARYNGEAL SQUAMOUS CELL CARCINOMAS
bioRxiv (Cold Spring Harbor Laboratory)·2026·DOI
8
Establishing primary tumor cell lines in dogs: Challenges and Ki-67 correlation
Brazilian Journal of Veterinary Pathology·2026·DOI
9
Computed Tomography Imaging for the Diagnosis of Primary Sarcomatoid Carcinoma of the Lung: A Case Report
Discovery Medicine·2025·DOI

Rate this reagent

Used this in your lab? Leave a quick rating. Reviews are anonymous and verified by academic email before they appear.

Your email is never shown publicly.